Another key takeaway I had:
it seems like the AML trials with Otsuka won't really start enrolling until we have the trial sites in Europe online. That is expected to be soon but it's also near the end of the year. But we haven't received any indication of the big pharma marketing plan from end of year being delayed...so this speaks to the confidence the team has in the trials I guess.
Although, I suppose BP can start to be engaged on the cardio protection side as well. if an announcement relating to that drops first I'd be curious to see the market reaction given they don't seem to really be aware of it.
RAC media coverage, page-1095
-
- There are more pages in this discussion • 1,194 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
0.010(0.64%) |
Mkt cap ! $267.5M | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.64 | $1.55 | $134.0K | 84.34K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6283 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.60 | 6559 | 2 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |